Introduction. Primary Sjogren's syndrome (pSS) is an autoimmune disease characterized by the production of pathogenic autoreactive antibodies. Despite the T cell involvement, in the physiopathology of this disease, is welldocumented, less information is available to describe the role of B cells. The etiology of this pathology is poorly understood. Nevertheless, some elements are pointed out including infections, epigenetic mechanisms, etc. Among them, glycosylation, as a physiological process, was also described as playing a key role in the development of various pathological disorders such as cancers. In autoimmunity, abnormal glycosylation of T cell markers takes place in SLE as well as on autoantibodies in pSS suggesting that dysregulation could occur in B cells. Material and methods. The aim of this project was to study, by cytometry, B cell subset glycosylation in the context of primary Sjögren's syndrome, to identify any potential alteration, and to extend the glycoprofile for serum proteins including immunoglobulins using ELISA assay. Results. We were able to demonstrate, specific glycoprofiles on B cell subsets such as N and O-glycosylation during B cell differentiation were altered in pSS. As an example of specific glycosylation, B cell hyposialylation was observed but no impairment in fucosylation was noticed. Interestingly, similar observations were obtained with the sera and immunoglobulins of these patients. Conclusions. This clearly points out that any perturbation of natural glycosylation processes in cells especially in B lymphocytes leads to the development of pathogenic autoantibodies. The correlation between the intensity of Clinical and Experimental Rheumatology 2022 15th International Symposium on Sjögren's Syndrome these alterations and the severity of autoimmune diseases could establish glycosylation as a biomarker of choice to identify the development of the pathology in patients, the physiopathology as well as the development of adapted therapeutics for them.